Global Cell Analysis Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

List of Tables

The global demand for Cell Analysis Market is presumed to reach the market size of nearly USD 45.8 BN by 2030 from USD 18.9 BN in 2022 with a CAGR of 11.7% under the study period 2023 - 2030.

Cell analysis refers to the study and examination of cells using various scientific techniques and tools. It involves analysing the structure, composition, behaviour, and functions of cells to gain a better understanding of their biology and role in living organisms. It is a fundamental aspect of biological and medical research, enabling scientists to investigate cellular processes, mechanisms, and interactions. Cell analysis techniques encompass a wide range of methods, including microscopy, flow cytometry, cell culture, molecular biology techniques, and advanced imaging technologies. These techniques allow researchers to visualise and analyse cells at the microscopic and molecular levels, studying their morphology, organelles, biomolecules, gene expression, protein localisation, and cell signalling pathways.

MARKET DYNAMICS:

Technological advancements play a crucial role, as innovations in imaging techniques, high-throughput screening, and molecular biology tools enable researchers to analyse cells at a higher resolution and extract more detailed information. The increasing focus on research and development activities across sectors such as pharmaceuticals and biotechnology drives the demand for cell analysis products and services. The rising prevalence of chronic diseases also fuels the need for this analysis in diagnostic and therapeutic applications as researchers seek to understand disease mechanisms and develop effective treatments. The shift towards personalised medicine also contributes to market growth, as cell analysis techniques enable the characterisation of specific cellular markers and genetic variations for tailored treatment approaches. Government funding and support, along with the development of the biopharmaceutical industry, further drive the market by promoting research and innovation in cell analysis.

The research covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cell analysis. The growth and trends of cell analysis industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the cell analysis market provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

Reagents & Consumables
Instruments
Accessories
Software
Service

By Technique

Flow Cytometry
PCR
Cell Microarrays
Microscopy
Spectrophotometry
High Content Screening
Other Techniques

By Process

Cell Identification
Cell Viability
Cell Signaling Pathways/Signal Transduction
Cell Proliferation
Cell Counting And Quality Control
Cell Interaction
Cell Structure Study
Target Identification And Validation
Single-Cell Analysis

By End User

Pharmaceutical & Biotechnology Companies
Hospitals And Clinical Testing Laboratories
Academic And Research Institutes
Other

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Cell Analysis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cell analysis market include Danaher (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), General Electric (US), Merck KGaA (US), Agilent Technologies (US), Olympus Corporation (Japan), Miltenyi Biotec (US), Bio-Rad Laboratories (US), BioStatus Limited (UK), Fluidigm Corporation (US), NanoCellect Biomedical (US), Cell Biolabs (US), Creative Bioarray (US), Meiji Techna (US), Promega Corporation (US), PerkinElmer (US), Tecan Trading AG (Switzerland), CELLINK (US), QIAGEN (Germany), Corning Incorporated (US), 10x Genomics (US), and Illumina (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized as per your need.

Product Code: VMR112111526

1 . PREFACE

1.1. Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . CELL ANALYSIS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product & Service
- 3.7.2 Market Attractiveness Analysis By Technique
- 3.7.3 Market Attractiveness Analysis By Process
- 3.7.4 Market Attractiveness Analysis By End User
- 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CELL ANALYSIS MARKET ANALYSIS BY PRODUCT & SERVICE

5.1 Overview by Product & Service
5.2 Historical and Forecast Data
5.3 Analysis by Product & Service
5.4 Reagents & Consumables Historic and Forecast Sales by Regions
5.5 Instruments Historic and Forecast Sales by Regions
5.6 Accessories Historic and Forecast Sales by Regions
5.7 Software Historic and Forecast Sales by Regions
5.8 Service Historic and Forecast Sales by Regions

6 . GLOBAL CELL ANALYSIS MARKET ANALYSIS BY TECHNIQUE

6.1 Overview by Technique
6.2 Historical and Forecast Data
6.3 Analysis by Technique
6.4 Flow Cytometry Historic and Forecast Sales by Regions
6.5 PCR Historic and Forecast Sales by Regions
6.6 Cell Microarrays Historic and Forecast Sales by Regions
6.7 Microscopy Historic and Forecast Sales by Regions
6.8 Spectrophotometry Historic and Forecast Sales by Regions
6.9 High Content Screening Historic and Forecast Sales by Regions
6.10. Other Techniques Historic and Forecast Sales by Regions

7 . GLOBAL CELL ANALYSIS MARKET ANALYSIS BY PROCESS

7.1 Overview by Process
7.2 Historical and Forecast Data
7.3 Analysis by Process
7.4 Cell Identification Historic and Forecast Sales by Regions
7.5 Cell Viability Historic and Forecast Sales by Regions
7.6 Cell Signaling Pathways/Signal Transduction Historic and Forecast Sales by Regions
7.7 Cell Proliferation Historic and Forecast Sales by Regions
7.8 Cell Counting and Quality Control Historic and Forecast Sales by Regions
7.9 Cell Interaction Historic and Forecast Sales by Regions
7.10. Cell Structure Study Historic and Forecast Sales by Regions
7.11 Target Identification and Validation Historic and Forecast Sales by Regions
7.12 Single-Cell Analysis Historic and Forecast Sales by Regions

8 . GLOBAL CELL ANALYSIS MARKET ANALYSIS BY END USER

8.1 Overview by End User
8.2 Historical and Forecast Data
8.3 Analysis by End User
8.4 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
8.5 Hospitals And Clinical Testing Laboratories Historic and Forecast Sales by Regions
8.6 Academic And Research Institutes Historic and Forecast Sales by Regions
8.7 Other Historic and Forecast Sales by Regions

9 . GLOBAL CELL ANALYSIS MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Data Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Data Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Data Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Data Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Data Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE CELL ANALYSIS COMPANIES

10.1. Cell Analysis Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF CELL ANALYSIS INDUSTRY

11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. Danaher (US)
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Thermo Fisher Scientific (US)
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Becton
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Dickinson And Company (US)
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. General Electric (US)
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Merck KGaA (US)
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. Agilent Technologies (US)
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. Olympus Corporation (Japan)
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. Miltenyi Biotec (US)
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. Bio-Rad Laboratories (US)
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments
11.13. BioStatus Limited (UK)
- 11.13.1. Company Overview
- 11.13.2. Company Revenue
- 11.13.3. Products
- 11.13.4. Recent Developments
11.14. Fluidigm Corporation (US)
- 11.14.1. Company Overview
- 11.14.2. Company Revenue
- 11.14.3. Products
- 11.14.4. Recent Developments
11.15. NanoCellect Biomedical (US)
- 11.15.1. Company Overview
- 11.15.2. Company Revenue
- 11.15.3. Products
- 11.15.4. Recent Developments
11.16. Cell Biolabs (US)
- 11.16.1. Company Overview
- 11.16.2. Company Revenue
- 11.16.3. Products
- 11.16.4. Recent Developments
11.17. Creative Bioarray (US)
- 11.17.1. Company Overview
- 11.17.2. Company Revenue
- 11.17.3. Products
- 11.17.4. Recent Developments
11.18. Meiji Techna (US)
- 11.18.1. Company Overview
- 11.18.2. Company Revenue
- 11.18.3. Products
- 11.18.4. Recent Developments
11.19. Promega Corporation (US)
- 11.19.1. Company Overview
- 11.19.2. Company Revenue
- 11.19.3. Products
- 11.19.4. Recent Developments
11.20. PerkinElmer (US)
- 11.20.1. Company Overview
- 11.20.2. Company Revenue
- 11.20.3. Products
- 11.20.4. Recent Developments
11.21. Tecan Trading AG (Switzerland)
- 11.21.1. Company Overview
- 11.21.2. Company Revenue
- 11.21.3. Products
- 11.21.4. Recent Developments
11.22. CELLINK (US)
- 11.22.1. Company Overview
- 11.22.2. Company Revenue
- 11.22.3. Products
- 11.22.4. Recent Developments
11.23. QIAGEN (Germany)
- 11.23.1. Company Overview
- 11.23.2. Company Revenue
- 11.23.3. Products
- 11.23.4. Recent Developments
11.24. Corning Incorporated (US)
- 11.24.1. Company Overview
- 11.24.2. Company Revenue
- 11.24.3. Products
- 11.24.4. Recent Developments
11.25. 10x Genomics (US)
- 11.25.1. Company Overview
- 11.25.2. Company Revenue
- 11.25.3. Products
- 11.25.4. Recent Developments
11.26. Illumina (US)
- 11.26.1. Company Overview
- 11.26.2. Company Revenue
- 11.26.3. Products
- 11.26.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies